Effects of methotrexate on inflammatory alterations induced by obesity: An in vivo and in vitro study
Effects of methotrexate on inflammatory alterations induced by obesity: An in vivo and in vitro study
复制标题
DOI:
10.1016/j.mce.2012.03.016
复制
发表时间:
2012-09-25
影响因子:
4.1
通讯作者:
Gambero, Alessandra
中科院分区:
文献类型:
--
作者:
DeOliveira, Caroline Candida;Acedo, Simone Coghetto;Gambero, Alessandra
Immunosuppressant drugs, such as methotrexate, are able to inhibit cytokine production and leukocyte migration to inflammatory foci; therefore, they could modify the establishment of inflammation in adipose tissue during obesity. Thus, we studied the effects of methotrexate in vivo on high-fat diet induced-obesity in mice and in vitro in isolated and co-cultured adipocytes and macrophages. Obese mice treated with methotrexate presented reduced serum levels of TNF-alpha, insulin and glucose, and an improvement of insulin sensitivity. Adipose tissue from these mice produced less proinflammatory (TNF-alpha, IL-6, leptin) and more anti-inflammatory adipokines (adiponectin and IL-10) associated with reduced macrophage infiltration and inflammation. Cytokine inhibition was also confirmed in isolated and co-cultured adipocytes and macrophages. Methotrexate presented anti-lipolytic effect in vivo and, in vitro through adenosine release. Drugs that combine anti-lipolytic effect and the ability to control inflammation in adipose tissue could play a role in the control of insulin resistance and other pathologies associated with obesity. (c) 2012 Elsevier Ireland Ltd. All rights reserved.